Statistics for BB Biotech AG (id:13037 BION)
Valuation metrics
Market cap
1.94B
Enterprise value
0.00
Trailing P/E (ttm)
15.46
Forward P/E
9.08
PEG ratio
9.08
Price/Sales (ttm)
-9.73
Price/Book (mrq)
3.00
Enterprise Value/Revenue
0.00
Enterprise Value/EBITDA
Overview
Shares outstanding
54.83M
Float
Shares short
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
108.26K
Average volume (90 days)
Price summary
52-Week low
34.50
52-Week high
49.80
52-Week change
-18.98%
Beta
3.00
50-Day moving average
37.14
200-Day moving average
39.77
Dividends and splits
Forward annual dividend rate
8.00
Forward annual dividend yield
3.00
Trailing annual dividend rate
2.00%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
5.61
Payout ratio
3.00
Dividend date
March 27, 2024
Ex-dividend date
March 25, 2024
Last split factor
2:1
Last split date
March 29, 2016
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
281.64%
Operating margin
-746,400.00%
Operational effectiveness
Return on assets
3.00%
Return on equity
-8.89%
Income statement
Revenue (ttm)
-3.64
Revenue per share (ttm)
-3.64
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-206,607,000.00
Diluted EPS (ttm)
-3.77
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
0.00
Total cash per share (mrq)
45.71
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
904.00%
Book value per share (mrq)
40.70
Cash flow
Cash flow statement
146.18M
Levered free cash flow (LFCF)
-206,607,000.00